Inclusion Body Myositis Market, By Treatment (Pharmacological Treatments, Non-Pharmacological Treatments), By Patient Population (Adult, Pediatric), By End User (Hospitals, Clinics), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.
The major players operating in the Inclusion body myositis market include Pfizer Inc., GlaxoSmithKline plc, Eli Lilly and Company, AbbVie Inc., Novartis AG, Alexion Pharmaceuticals, Orphazyme, Viela Bio, Sanofi, and Amgen.
Inclusion Body Myositis Market